AR113027A2 - PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER - Google Patents
PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCERInfo
- Publication number
- AR113027A2 AR113027A2 ARP180102713A ARP180102713A AR113027A2 AR 113027 A2 AR113027 A2 AR 113027A2 AR P180102713 A ARP180102713 A AR P180102713A AR P180102713 A ARP180102713 A AR P180102713A AR 113027 A2 AR113027 A2 AR 113027A2
- Authority
- AR
- Argentina
- Prior art keywords
- peptides
- cancer
- supports
- various types
- peptide combinations
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 201000011510 cancer Diseases 0.000 title abstract 2
- 230000001024 immunotherapeutic effect Effects 0.000 title abstract 2
- 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 230000005975 antitumor immune response Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente se refiere a péptidos, proteínas, ácidos nucleicos y células destinados a la utilización en métodos inmunoterapéuticos. En particular, la presente se refiere a la inmunoterapia contra el cáncer. Se refiere asimismo a epítopos peptídicos para linfocitos T asociados a tumores, solos o en combinación con otros péptidos asociados a tumores que, por ejemplo, pueden servir como principios activos farmacéuticos en composiciones vacunales destinadas a estimular respuestas inmunitarias antitumorales, o a estimular ex vivo linfocitos T que después serán transferidos a los pacientes. Los péptidos unidos a moléculas del complejo mayor de histocompatibilidad (MHC), o los péptidos como tales, también pueden ser dianas de anticuerpos, de receptores de linfocitos T solubles, y de otras moléculas de unión.This refers to peptides, proteins, nucleic acids, and cells for use in immunotherapeutic methods. In particular, this is concerned with immunotherapy against cancer. It also refers to peptide epitopes for tumor-associated T lymphocytes, alone or in combination with other tumor-associated peptides, which, for example, can serve as active pharmaceutical ingredients in vaccine compositions intended to stimulate antitumor immune responses, or to stimulate T lymphocytes ex vivo. which will then be transferred to the patients. Peptides bound to major histocompatibility complex (MHC) molecules, or peptides as such, can also be targets of antibodies, soluble T cell receptors, and other binding molecules.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562211276P | 2015-08-28 | 2015-08-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR113027A2 true AR113027A2 (en) | 2020-01-15 |
Family
ID=60451268
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102632A AR105851A1 (en) | 2015-08-28 | 2016-08-29 | PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP180102713A AR113027A2 (en) | 2015-08-28 | 2018-09-21 | PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP210101474A AR122217A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP210101475A AR122218A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160102632A AR105851A1 (en) | 2015-08-28 | 2016-08-29 | PEPTIDES, COMBINATIONS OF PEPTIDES AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210101474A AR122217A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
| ARP210101475A AR122218A2 (en) | 2015-08-28 | 2021-05-31 | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
Country Status (2)
| Country | Link |
|---|---|
| AR (4) | AR105851A1 (en) |
| MA (2) | MA43091A1 (en) |
-
2016
- 2016-08-26 MA MA43091A patent/MA43091A1/en unknown
- 2016-08-26 MA MA42022A patent/MA42022A1/en unknown
- 2016-08-29 AR ARP160102632A patent/AR105851A1/en not_active Application Discontinuation
-
2018
- 2018-09-21 AR ARP180102713A patent/AR113027A2/en not_active Application Discontinuation
-
2021
- 2021-05-31 AR ARP210101474A patent/AR122217A2/en not_active Application Discontinuation
- 2021-05-31 AR ARP210101475A patent/AR122218A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MA42022A1 (en) | 2018-07-31 |
| AR122218A2 (en) | 2022-08-24 |
| AR122217A2 (en) | 2022-08-24 |
| MA43091A1 (en) | 2019-08-30 |
| AR105851A1 (en) | 2017-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023001346A1 (en) | Use of peptides in immunotherapy against small cell lung cancer and others. | |
| CR20200493A (en) | NEW PEPTIDES, PEPTIDE COMBINATIONS AND SUPPORTS FOR USE IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER (Divisional 2018-174) | |
| CL2018000780A1 (en) | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other types of cancer | |
| CO2018008763A2 (en) | Peptides, combinations of peptides and cells for use in immunotherapy against urinary bladder cancer and other types of cancer | |
| CO2018002202A2 (en) | Peptides and combinations of peptides for immunotherapy against prostate cancer and other types of cancer | |
| CR20180245A (en) | NEW PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TYPES OF CANCER | |
| CR20210036A (en) | TREATMENT AGAINST UTERAL CANCER | |
| CO2017012891A2 (en) | Peptides and combinations of peptides for immunotherapy against ovarian cancer and other types of cancer | |
| CR20180051A (en) | NEW CELLULAR EPITHOPES AND NEW COMBINATIONS OF CELLULAR EPITHOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER TYPES OF CANCER. | |
| CR20200592A (en) | Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers | |
| MX2018000543A (en) | NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARY EPITELIAL CANCER AND OTHER TYPES OF CANCER. | |
| CR20200561A (en) | Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers | |
| CR20180001A (en) | NEW PEPTIDES AND NEW COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER TYPES OF CANCER. | |
| CO2018000245A2 (en) | Peptides and combinations of peptides for immunotherapy against pancreatic cancer and other types of cancer | |
| CO2019012077A2 (en) | Peptides and combinations thereof for use in immunotherapy against various types of cancer | |
| CL2018000545A1 (en) | New peptides, combinations of peptides and supports for use in the immunotherapeutic treatment of various types of cancer. | |
| CO2018004869A2 (en) | Peptides and combination of peptides for immunotherapy against various types of cancer | |
| CO2017010830A2 (en) | Peptides and combinations of peptides and supports | |
| CL2023001324A1 (en) | Peptides, combinations, cells for immunotherapy against bladder cancer and other cancers | |
| CO2017009101A2 (en) | Peptides and peptide combination | |
| CO2018000247A2 (en) | New cell epitopes and new combinations of cell epitopes for use in the immunotherapy of myeloma and other types of cancer | |
| AR105138A1 (en) | CELLULAR EPITHOPES AND COMBINATIONS OF CELLULAR EPITHOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER TYPES OF CANCER | |
| AR122217A2 (en) | PEPTIDES AND SUPPORTS USEFUL IN THE IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS TYPES OF CANCER |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |